Real-World Treatment Trends Among Patients with Metastatic Castration-Sensitive Prostate Cancer: Results from an International Study

BACKGROUND: Continuous androgen deprivation therapy ± first-generation non-steroidal antiandrogen was previously the standard-of-care for patients with metastatic castration-sensitive prostate cancer (mCSPC). Treatment intensification with novel hormonal therapy (NHT) or taxane chemotherapy is now a...

Descripción completa

Detalles Bibliográficos
Autores principales: Barata, Pedro C, Leith, Andrea, Ribbands, Amanda, Montgomery, Rachel, Last, Matthew, Arondekar, Bhakti, Ivanova, Jasmina, Niyazov, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485292/
https://www.ncbi.nlm.nih.gov/pubmed/37014080
http://dx.doi.org/10.1093/oncolo/oyad045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485292/
https://www.ncbi.nlm.nih.gov/pubmed/37014080
http://dx.doi.org/10.1093/oncolo/oyad045

Ejemplares similares